Dyskeratosis Congenita: A Case Report of a Patient With Coronary Artery Disease

被引:0
作者
Ghaly, Michael [1 ]
Ghaly, Mark [2 ]
Harris, Samuel [2 ]
机构
[1] Baptist Mem Hosp, Internal Med, Oxford, MS 38655 USA
[2] Georgia Southern Univ, Biol, Savannah, GA USA
关键词
pulmonary fibrosis; cardiovascular disease (cvd); cardiovascular prevention; aplastic anemia; st-elevation myocardial infarction (stemi); coronary artery by-pass grafting; telomere shortening; heart failure with reduced ejection fraction; dyskeratosis congenita; coronary artery disease; TELOMERES;
D O I
10.7759/cureus.40939
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical evidence demonstrates that patients with telomere biology disorders, such as dyskeratosis congenita, are more prone to coronary artery disease. We present the case of a 43-year-old female diagnosed with dyskeratosis congenita with critical cardiovascular disease. She underwent coronary artery bypass graft (CABG) with improvement of her cardiac function. Although this is a rare genetic disease, further studies are warranted to investigate the underlying pathophysiology of cardiovascular disease in patients with dyskeratosis congenita.
引用
收藏
页数:5
相关论文
共 6 条
  • [1] Telomeres and age-related disease: how telomere biology informs clinical paradigms
    Armanios, Mary
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03) : 996 - 1002
  • [2] Lipid and inflammatory markers for the prediction of coronary artery disease: A multi-marker approach
    Bogavac-Stanojevic, Natasa
    Jelic-Ivanovic, Zorana
    Spasojevic-Kahmanovska, Vesna
    Spasic, Slavica
    Kalimanovska-Ostric, Dimitra
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (13-14) : 1000 - 1006
  • [3] Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence
    Hewitt, Graeme
    Jurk, Diana
    Marques, Francisco D. M.
    Correia-Melo, Clara
    Hardy, Timothy
    Gackowska, Agata
    Anderson, Rhys
    Taschuk, Morgan
    Mann, Jelena
    Passos, Joao F.
    [J]. NATURE COMMUNICATIONS, 2012, 3
  • [4] Shiferaw Bethel, 2015, J Clin Med Res, V7, P361, DOI 10.14740/jocmr2056w
  • [5] The diagnosis and treatment of dyskeratosis congenita: a review
    Soledad Fernandez Garcia, M.
    Teruya-Feldstein, Julie
    [J]. JOURNAL OF BLOOD MEDICINE, 2014, 5 : 157 - 167
  • [6] von Zglinicki T, 2005, CURR MOL MED, V5, P197